vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and BrightSpire Capital, Inc. (BRSP). Click either name above to swap in a different company.
BrightSpire Capital, Inc. is the larger business by last-quarter revenue ($83.2M vs $44.9M, roughly 1.9× AbCellera Biologics Inc.). BrightSpire Capital, Inc. runs the higher net margin — -17.3% vs -19.9%, a 2.7% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -0.4%). BrightSpire Capital, Inc. produced more free cash flow last quarter ($55.1M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -6.8%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Oakley Capital Investments, is a large British investment trust focused on investments in mid-market companies in the business services, consumer, education and technology sectors. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
ABCL vs BRSP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $83.2M |
| Net Profit | $-8.9M | $-14.4M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | — |
| Net Margin | -19.9% | -17.3% |
| Revenue YoY | 788.4% | -0.4% |
| Net Profit YoY | 73.9% | 27.3% |
| EPS (diluted) | $-0.03 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $83.2M | ||
| Q3 25 | $9.0M | $83.9M | ||
| Q2 25 | $17.1M | $85.9M | ||
| Q1 25 | $4.2M | $77.6M | ||
| Q4 24 | $5.0M | $83.5M | ||
| Q3 24 | $6.5M | $88.2M | ||
| Q2 24 | $7.3M | $91.4M | ||
| Q1 24 | $10.0M | $95.8M |
| Q4 25 | $-8.9M | $-14.4M | ||
| Q3 25 | $-57.1M | $984.0K | ||
| Q2 25 | $-34.7M | $-23.1M | ||
| Q1 25 | $-45.6M | $5.3M | ||
| Q4 24 | — | $-19.7M | ||
| Q3 24 | $-51.1M | $12.7M | ||
| Q2 24 | $-36.9M | $-67.9M | ||
| Q1 24 | $-40.6M | $-57.1M |
| Q4 25 | -63.7% | — | ||
| Q3 25 | -851.8% | -1.7% | ||
| Q2 25 | -290.2% | -54.5% | ||
| Q1 25 | -1479.6% | 5.1% | ||
| Q4 24 | — | -24.9% | ||
| Q3 24 | -1439.4% | 13.2% | ||
| Q2 24 | -1276.2% | -74.9% | ||
| Q1 24 | -551.5% | -59.4% |
| Q4 25 | -19.9% | -17.3% | ||
| Q3 25 | -637.8% | 1.2% | ||
| Q2 25 | -203.3% | -26.9% | ||
| Q1 25 | -1077.2% | 6.9% | ||
| Q4 24 | — | -23.7% | ||
| Q3 24 | -785.4% | 14.4% | ||
| Q2 24 | -504.3% | -74.2% | ||
| Q1 24 | -408.0% | -59.6% |
| Q4 25 | $-0.03 | $-0.11 | ||
| Q3 25 | $-0.19 | $0.00 | ||
| Q2 25 | $-0.12 | $-0.19 | ||
| Q1 25 | $-0.15 | $0.04 | ||
| Q4 24 | — | $-0.16 | ||
| Q3 24 | $-0.17 | $0.09 | ||
| Q2 24 | $-0.13 | $-0.53 | ||
| Q1 24 | $-0.14 | $-0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $66.8M |
| Total DebtLower is stronger | — | $2.5B |
| Stockholders' EquityBook value | $966.9M | $938.4M |
| Total Assets | $1.4B | $3.6B |
| Debt / EquityLower = less leverage | — | 2.63× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $66.8M | ||
| Q3 25 | $83.2M | $113.4M | ||
| Q2 25 | $92.4M | $154.3M | ||
| Q1 25 | $159.3M | $200.9M | ||
| Q4 24 | $156.3M | $302.2M | ||
| Q3 24 | $126.6M | $263.8M | ||
| Q2 24 | $148.3M | $203.3M | ||
| Q1 24 | $123.6M | $221.5M |
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | $966.9M | $938.4M | ||
| Q3 25 | $964.0M | $976.4M | ||
| Q2 25 | $1.0B | $994.4M | ||
| Q1 25 | $1.0B | $1.0B | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.1B | $1.2B |
| Q4 25 | $1.4B | $3.6B | ||
| Q3 25 | $1.4B | $3.3B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.3B | $3.6B | ||
| Q4 24 | $1.4B | $3.7B | ||
| Q3 24 | $1.4B | $3.8B | ||
| Q2 24 | $1.4B | $3.8B | ||
| Q1 24 | $1.5B | $3.9B |
| Q4 25 | — | 2.63× | ||
| Q3 25 | — | 2.22× | ||
| Q2 25 | — | 2.27× | ||
| Q1 25 | — | 2.27× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.36× | ||
| Q2 24 | — | 2.28× | ||
| Q1 24 | — | 2.17× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $73.0M |
| Free Cash FlowOCF − Capex | $-44.6M | $55.1M |
| FCF MarginFCF / Revenue | -99.4% | 66.2% |
| Capex IntensityCapex / Revenue | 21.9% | 21.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $102.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $73.0M | ||
| Q3 25 | $-52.6M | $29.9M | ||
| Q2 25 | $-32.4M | $17.4M | ||
| Q1 25 | $-11.6M | $10.5M | ||
| Q4 24 | $-108.6M | $103.4M | ||
| Q3 24 | $-28.9M | $31.3M | ||
| Q2 24 | $-30.0M | $22.9M | ||
| Q1 24 | $-41.7M | $24.6M |
| Q4 25 | $-44.6M | $55.1M | ||
| Q3 25 | $-61.5M | $27.4M | ||
| Q2 25 | $-45.8M | $11.6M | ||
| Q1 25 | $-22.2M | $8.0M | ||
| Q4 24 | $-187.0M | $97.3M | ||
| Q3 24 | $-47.4M | $28.3M | ||
| Q2 24 | $-50.1M | $22.7M | ||
| Q1 24 | $-65.8M | $22.2M |
| Q4 25 | -99.4% | 66.2% | ||
| Q3 25 | -687.0% | 32.7% | ||
| Q2 25 | -267.9% | 13.4% | ||
| Q1 25 | -524.0% | 10.3% | ||
| Q4 24 | -3702.8% | 116.6% | ||
| Q3 24 | -728.4% | 32.1% | ||
| Q2 24 | -683.8% | 24.9% | ||
| Q1 24 | -661.5% | 23.2% |
| Q4 25 | 21.9% | 21.6% | ||
| Q3 25 | 99.7% | 2.9% | ||
| Q2 25 | 78.2% | 6.8% | ||
| Q1 25 | 251.1% | 3.2% | ||
| Q4 24 | 1552.7% | 7.3% | ||
| Q3 24 | 284.6% | 3.4% | ||
| Q2 24 | 274.6% | 0.1% | ||
| Q1 24 | 242.5% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 30.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.46× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
